Insider Transactions
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Feb 15, 2012 |
Director, EVP CSO President Regeneron Re
|
Director, EVP CSO President Regeneron Re | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 266 | -- | 10,369 |
| Jan 06, 2012 |
Director, EVP, CSO & Pres, REGN Res Labs
|
Director, EVP, CSO & Pres, REGN Res Labs | Form 4 | Other acquisition or disposition | -- | -- | 5,390 |
| Jan 05, 2012 |
Director, EVP, CSO & Pres, REGN Res Labs
|
Director, EVP, CSO & Pres, REGN Res Labs | Form 4 | Open market or private sale of non-derivative or derivative security | 27,713 | $58.00 | 833,041 |
| Dec 16, 2011 |
Director, EVP CSO President Regeneron Re
|
Director, EVP CSO President Regeneron Re | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 1,921 | -- | 1,921 |
| Dec 16, 2011 |
Director, EVP CSO President Regeneron Re
|
Director, EVP CSO President Regeneron Re | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 150,000 | -- | 244,048 |
| Dec 16, 2011 |
Director, EVP CSO President Regeneron Re
|
Director, EVP CSO President Regeneron Re | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 158,079 | -- | 158,079 |
| Dec 15, 2011 |
Director, EVP CSO President Regeneron Re
|
Director, EVP CSO President Regeneron Re | Form 4 | Other acquisition or disposition | -- | -- | 5,390 |
| Dec 14, 2011 |
Director, EVP CSO President Regeneron Re
|
Director, EVP CSO President Regeneron Re | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 38,516 | $51.18 | 860,754 |
| Dec 02, 2011 |
Director, EVP CSO President Regeneron Re
|
Director, EVP CSO President Regeneron Re | Form 4 | Other acquisition or disposition | -- | -- | 5,390 |
| Dec 01, 2011 |
Director, EVP CSO President Regeneron Re
|
Director, EVP CSO President Regeneron Re | Form 4 | Open market or private sale of non-derivative or derivative security | 3,300 | $58.86 | 923,683 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.